The Food & Drug Administration (FDA) announced September 4 that it will hold a Medical Devices Advisory Committee Meeting in November to discuss ethylene oxide (EO) sterilization of medical devices, including methods to reduce EO emissions.
The committee also will provide recommendations on reducing infection risks from reprocessed duodenoscopes.
The FDA is establishing a docket for public comments on the meeting, which will close on December 6, 2019. Comments received on or before October 21 will be provided to the committee. Comments received after that date will be taken into consideration by the FDA.Read More >>